California-based Notable Labs has raised $40m in series B funding to develop its AI-based cancer treatment tool. The investment was co-led by B Capital Group and Lifeforce Capital. AI is already being used for a variety of medical applications, including the diagnosis of cancer, but it can also be applied to other areas such as speech recognition, machine translation, image recognition or even self-driving cars. The company claims its system increases the efficiency of the treatment process, while also accelerating drug development.
California-based Notable Labs has raised $40m in series B funding to develop its AI-based cancer treatment tool. The investment was co-led by B Capital Group and Lifeforce Capital. Notable uses automated lab testing technology to predict the impact of different cancer therapies on individual patients. The company claims its system increases the efficiency of the treatment process, while also accelerating drug development.